NCT03847532 (MAP) is a NA clinical trial of Sanger sequencing method in MutYH-associated Polyposis, sponsored by State Scientific Centre of Coloproctology, Russian Federation.

Who is sponsoring NCT03847532?

NCT03847532 is sponsored by State Scientific Centre of Coloproctology, Russian Federation.

What drugs are being tested in NCT03847532?

Interventions in NCT03847532: Sanger sequencing method.

What condition does NCT03847532 study?

NCT03847532 studies MutYH-associated Polyposis.

Is NCT03847532 still recruiting?

NCT03847532 is currently status unknown. Last updated 4 April 2019.

Last reviewed 2019-04-04 · How we verify

NCT03847532: MAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MUTYH-associated Polyposis

Status unknown NA Last updated 4 April 2019

What this trial tests

NA trial testing Sanger sequencing method in MutYH-associated Polyposis in 25 participants. Status unknown.

Timeline

10 October 2018

Primary endpoint
10 October 2020

31 May 2021

Quick facts

Lead sponsor	State Scientific Centre of Coloproctology, Russian Federation
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	25
Start date	10 October 2018
Primary completion	10 October 2020
Estimated completion	31 May 2021
Sites	1 location across Russia

Drugs / interventions tested

Sanger sequencing method

Conditions studied

MutYH-associated Polyposis — all drugs for MutYH-associated Polyposis →

Sponsor

State Scientific Centre of Coloproctology, Russian Federation — full company profile →

Who can join

Adults 18 to 71, any sex, with MutYH-associated Polyposis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is single-center, prospective, non-randomized study

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other State Scientific Centre of Coloproctology, Russian Federation trials

Trials by the same sponsor.

NCT07268261 — Combined Method of Surgical Treatment of Anal Fissure · NA · recruiting
NCT05598164 — Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure · NA · unknown
NCT05495776 — Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer · recruiting
NCT05117697 — Surgical Treatment of a Chronic Anal Fissure · NA · unknown
NCT05228054 — Treatment of Hemorrhoid With 1940nm Laser Procedure · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03847532 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by State Scientific Centre of Coloproctology, Russian Federation
Last refreshed: 4 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03847532.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing